These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19136636)

  • 1. 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.
    Torreira E; Tortajada A; Montes T; Rodríguez de Córdoba S; Llorca O
    Proc Natl Acad Sci U S A; 2009 Jan; 106(3):882-7. PubMed ID: 19136636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase.
    Torreira E; Tortajada A; Montes T; Rodríguez de Córdoba S; Llorca O
    J Immunol; 2009 Dec; 183(11):7347-51. PubMed ID: 19890040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.
    Bettoni S; Bresin E; Remuzzi G; Noris M; Donadelli R
    J Biol Chem; 2016 Apr; 291(15):8214-30. PubMed ID: 26903516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of C3b in complex with factors B and D give insight into complement convertase formation.
    Forneris F; Ricklin D; Wu J; Tzekou A; Wallace RS; Lambris JD; Gros P
    Science; 2010 Dec; 330(6012):1816-20. PubMed ID: 21205667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
    Harris CL; Pettigrew DM; Lea SM; Morgan BP
    J Immunol; 2007 Jan; 178(1):352-9. PubMed ID: 17182573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.
    Ponnuraj K; Xu Y; Macon K; Moore D; Volanakis JE; Narayana SV
    Mol Cell; 2004 Apr; 14(1):17-28. PubMed ID: 15068800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
    van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
    Front Immunol; 2019; 10():2097. PubMed ID: 31552043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact.
    Pryzdial EL; Isenman DE
    J Biol Chem; 1987 Feb; 262(4):1519-25. PubMed ID: 3643213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
    Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
    J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.
    Janssen BJ; Gomes L; Koning RI; Svergun DI; Koster AJ; Fritzinger DC; Vogel CW; Gros P
    EMBO J; 2009 Aug; 28(16):2469-78. PubMed ID: 19574954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism.
    Andersen JF; Lei H; Strayer EC; Kanai T; Pham V; Pan XZ; Alvarenga PH; Gerber GF; Asojo OA; Francischetti IMB; Brodsky RA; Valenzuela JG; Ribeiro JMC
    Blood; 2023 Jun; 141(25):3109-3121. PubMed ID: 36947859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).
    Harris CL; Abbott RJ; Smith RA; Morgan BP; Lea SM
    J Biol Chem; 2005 Jan; 280(4):2569-78. PubMed ID: 15536079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional analysis of a C3b-specific antibody that selectively inhibits the alternative pathway of complement.
    Katschke KJ; Stawicki S; Yin J; Steffek M; Xi H; Sturgeon L; Hass PE; Loyet KM; Deforge L; Wu Y; van Lookeren Campagne M; Wiesmann C
    J Biol Chem; 2009 Apr; 284(16):10473-9. PubMed ID: 19196712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decay-accelerating factor (DAF), complement receptor 1 (CR1), and factor H dissociate the complement AP C3 convertase (C3bBb) via sites on the type A domain of Bb.
    Hourcade DE; Mitchell L; Kuttner-Kondo LA; Atkinson JP; Medof ME
    J Biol Chem; 2002 Jan; 277(2):1107-12. PubMed ID: 11694537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb).
    Bexborn F; Andersson PO; Chen H; Nilsson B; Ekdahl KN
    Mol Immunol; 2008 Apr; 45(8):2370-9. PubMed ID: 18096230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of the zymogenicity and the substrate-induced activity enhancement of complement factor D.
    Dani R; Oroszlán G; Martinusz R; Farkas B; Dobos B; Vadas E; Závodszky P; Gál P; Dobó J
    Front Immunol; 2023; 14():1197023. PubMed ID: 37283768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
    Rooijakkers SH; Wu J; Ruyken M; van Domselaar R; Planken KL; Tzekou A; Ricklin D; Lambris JD; Janssen BJ; van Strijp JA; Gros P
    Nat Immunol; 2009 Jul; 10(7):721-7. PubMed ID: 19503103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational changes during the assembly of factor B from its domains by (1)H NMR spectroscopy and molecular modelling: their relevance to the regulation of factor B activity.
    Hinshelwood J; Perkins SJ
    J Mol Biol; 2000 Sep; 301(5):1267-85. PubMed ID: 10966820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models.
    Subías M; Tortajada A; Gastoldi S; Galbusera M; López-Perrote A; Lopez Lde J; González-Fernández FA; Villegas-Martínez A; Dominguez M; Llorca O; Noris M; Morgan BP; Rodríguez de Córdoba S
    J Immunol; 2014 Dec; 193(11):5567-75. PubMed ID: 25355917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.